medigraphic.com
ISSN 1405-8871 (Print)

2016, Number 1

<< Back Next >>

Aten Fam 2016; 23 (1)

Cervical Cancer, a Three-year Report in a Medical Ambulatory Care Unit

Pérez-Ponce P, López-Ledezma L, Méndez-González MG, Vázquez-Martínez VH

Language: Spanish
References: 27
Page: 4-7
PDF size: 387.73 Kb.


ABSTRACT

Objective: to determine the epidemiological characteristics of cervical cancer during a three-year period in a medical ambulatory care unit (macu) of the General Hospital of the zone 15 in Reynosa, Tamaulipas. Methods: the information was gathered in the care unit database, from March to October 2012. This base contained a follow-up of 1 663 women who diagnosed dysplasia and, uterine and cervical cancer; in addition, it was provided monitoring care and treatment for 8 489 women. Results: 59.1% were probable cases and in 40.9% dysplasia and cancer were confirmed. The most affected group was that of women between 25 and 44 years old. 17.74% was estimated as a percentage of abandonment of treatment and 54.7% of correlation between cytological and histopathological. Conclusions: as this is a descriptive study, it only allowed us to know the frequency but not the reason for abandoning the treatment. It would be necessary to conduct a follow-up study to determine the reasons for discontinuation of treatment.


REFERENCES

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: globocan 2008. Int Cancer. 2010,127:2893-917.

  2. Munoz N, Bosch FX, De SS, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-27.

  3. globocan. Cancer Fact Sheet: Cervical Cancer Estimated Incidence and Prevalence Worldwide in 2012. International Agency for Research on Cancer [Internet]. 2012; [citado 2014 Ene 31]. Disponible en: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx

  4. Clarke, et al. A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica. bmc Infectious Diseases. 2013;13:308.

  5. Ezechi, et al. The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in hiv positive Nigerian women. Virology Journal. 2014;11:5.

  6. Reeler A, Qiao Y, Dare L, Li J, Zhang AL, Saba J. Womens cancers in developing countries: from research to an integrated health systems approach. Asian Pac J Cancer Prev. 2009;10(3):519-26.

  7. Winer RL, Feng Q, Hughes JP, O’Reilly S, Kiviat NB, Koutsky LA. Risk of female human papillomavirus acquisition associated with first males sex partner. J Infect Dis. 2008;197:279-82.

  8. Burchell AN, Winer RL, De Sanjose S, Franco EL. Epidemiology and transmission dynamics of genital hpv infection. Vaccine. 2006;24 (Suppl 3:S3):52-61.

  9. Secretaría de Salud. Registro Histopatológico de Neoplasias Malignas. Compendio: mortalidad y morbilidad. México: Secretaría de Salud, Epidemiología; 2003.

  10. Sankaranarayann R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of screening methods for cervical neoplasia. International journal of gynaecology and obstetrics. The official organ of the International Federation of Gynaecology and Obstetrics. 2005;89(suppl 2):S4-S12.

  11. Prevención y detección oportuna del cáncer cérvico uterino en el primer nivel de atención. México: Secretaría de Salud; 2008.

  12. Norma Oficial Mexicana nom-014-SSA2-1994, para la prevención, tratamiento y control de cáncer del cuello del útero y de la mama en la atención primaria.

  13. Ferlay J, Bray F, Pisani P, Parkin DM. International Agency for Research on Cancer (iarc). globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide. CancerBase No. 5, version 2.0. Lyon, France: iarc Press; 2004.

  14. oms. Control integral del cáncer cervicouterino: guía de prácticas esenciales. Ginebra: Organización Mundial de la Salud; 2007.

  15. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-9.

  16. Bulkmans NW, Berkhof J, Rozendaal L, et al. Human papillomavirus dna testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 2007;370:1764-72.

  17. Dillner J, Rebolj M, Birembaut P, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. bmj. 2008;337:a1754.

  18. Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Canadian Cervical Cancer Screening Trial Study Group Human papillomavirus dna versus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007;357:1579-88.

  19. Naucler P, Ryd W, Törnberg S, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007;357:1589-97.

  20. Castle PE, Sadorra M, Lau T, Aldrich C, Garcia FA, Kornegay J. Evaluation of a prototype real-time pcr assay for carcinogenic human papillomavirus (hpv) detection and simultaneous hpv genotype 16 (hpv16) and hpv18 genotyping. J Clin Microbiol. 2009;47:3344-7.

  21. Donovan KA, Taliaferro LA, Alvarez EM, Jacobsen PB, Roetzheim RG, Wenham RM. Sexual health in women treated for cervical cancer: character istics and correlates. Gynecol Oncol. 2007;104(2):428-34.

  22. Lindau ST, Gavrilova N, Anderson D. Sexual morbidity in very long term survivors of vaginal and cervical cancer: a comparison to national norms. Gynecol Oncol. 2007;106(2):413-8.

  23. Fosså SR, Vassilopoulou-Sellin R, Dahl A. Long term physical sequelae after adult-onset cancer. J Cancer Survivorship. 2008;2(1):3-11.

  24. Bradley S, Rose S, Lutgendorf S, Costanzo E, Anderson B. Quality of life and mental health in cervical and endometrial cancer survivors. Gynecol Oncol. 2006;100(3):479-86.

  25. Sánchez-Barriga JJ. Tendencias de mortalidad por cáncer cervicouterino en las siete regiones socioeconómicas y en las 32 entidades federativas de México en los años 2000-2008. Gaceta Médica de México. 2012;148:42-51.

  26. Kamath R, Mahajan KS, Ashok L, Sanal TS. A study on risk factors of breast cancer among patients attending the tertiary care hospital, in udupi district. Indian J Community Med. 2013;28(2):95-9.

  27. Paolino M, Arrossi S. Analysis of the reasons for abandoning the follow-up and treatment process in women with pre-cancerous cervical lesions in the province of Jujuy: implications for health management. Salud colectiva. 2012;8(3):247-61.




2020     |     www.medigraphic.com